ProShare Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$141K Sell
25,804
-6,728
-21% -$37.7K ﹤0.01% 1661
2025
Q4
$228K Buy
32,532
+2,457
+8% +$19.2K ﹤0.01% 1630
2025
Q3
$232K Sell
30,075
-5,990
-17% -$46.8K ﹤0.01% 1612
2025
Q2
$314K Sell
36,065
-1,201
-3% -$8.71K ﹤0.01% 1412
2025
Q1
$297K Sell
37,266
-11,214
-23% -$113K ﹤0.01% 1419
2024
Q4
$441K Buy
48,480
+16,312
+51% +$157K ﹤0.01% 1352
2024
Q3
$295K Buy
+32,168
New +$266K ﹤0.01% 1478
2022
Q2
Sell
-3,676
Closed -$265K 2106
2022
Q1
$265K Sell
3,676
-345
-9% -$24.9K ﹤0.01% 1719
2021
Q4
$369K Buy
4,021
+252
+7% +$30.1K ﹤0.01% 1657
2021
Q3
$478K Sell
3,769
-979
-21% -$143K ﹤0.01% 1233
2021
Q2
$790K Buy
4,748
+2,309
+95% +$374K ﹤0.01% 1185
2021
Q1
$443K Buy
2,439
+225
+10% +$52.2K ﹤0.01% 1527
2020
Q4
$443K Buy
2,214
+802
+57% +$163K ﹤0.01% 1343
2020
Q3
$310K Buy
1,412
+210
+17% +$44.5K ﹤0.01% 1158
2020
Q2
$229K Sell
1,202
-4,318
-78% -$757K ﹤0.01% 1386
2020
Q1
$856K Sell
5,520
-6,000
-52% -$698K 0.01% 624
2019
Q4
$964K Buy
11,520
+1,687
+17% +$128K ﹤0.01% 807
2019
Q3
$666K Buy
9,833
+990
+11% +$65.2K ﹤0.01% 886
2019
Q2
$587K Sell
8,843
-1,266
-13% -$73.8K ﹤0.01% 952
2019
Q1
$562K Buy
10,109
+999
+11% +$61K ﹤0.01% 978
2018
Q4
$452K Sell
9,110
-1,544
-14% -$94.5K ﹤0.01% 984
2018
Q3
$920K Buy
10,654
+2,482
+30% +$177K 0.01% 858
2018
Q2
$474K Buy
8,172
+747
+10% +$36.5K ﹤0.01% 1145
2018
Q1
$299K Sell
7,425
-564
-7% -$21.3K ﹤0.01% 1325
2017
Q4
$278K Buy
+7,989
New +$265K ﹤0.01% 1435

Other funds holding TDOC

ProShare Advisors's TDOC Position: Q1 2026 in Review

ProShare Advisors reduced its Teladoc Health (TDOC) stake by 21% in Q1 2026, selling an estimated $37.7K and leaving 25,804 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #1661.

ProShare Advisors first reported a position in TDOC in Q4 2017 and has held it in 25 quarters since. The position peaked at $964K in Q4 2019. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • ProShare Advisors held 25,804 shares of Teladoc Health worth $141K as of Q1 2026.
  • ProShare Advisors sold 6,728 Teladoc Health shares in Q1 2026, an estimated $37.7K.
  • Teladoc Health made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1661 holding.
  • ProShare Advisors first reported a position in Teladoc Health in Q4 2017 and has held it in 25 quarters since.
  • ProShare Advisors's Teladoc Health position peaked at $964K in Q4 2019.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.